EGFR and gallbladder carcinoma: We previously reported that 15% of biliary tree and gallbladder carcinomas had EGFR gene mutations in the tyrosine kinase (TK) domain and that the mutations led to activation of one or both of the EGFR signal transduction pathways [13].